patents Archives

Psychedelics News

patents

Industry

15 Aug 2023

Cybin Granted U.S. Patent For Psilocybin Program

Newly granted U.S. patent covers composition of matter claims and treatment methods in support of the Company’s CYB003 program until 2041...

By Microdose NewsDesk

Law & Politics

6 Jul 2023

Pay-For-Success Contracts: An Open Source Alternative to Psychedelic Patents

The role of patents in the ongoing psychedelic renaissance incites robust debate. In this piece, we describe an alternative pay-for-success (PFS) contract system that can be used instead of patents...

By Microdose

Industry

13 Oct 2022

A Look at Web3 and Psychedelic IP

As companies move themselves toward potential commercialization of psychedelic medicines, a great deal of speculation and attention is being placed on intellectual property (IP) and the future of Web3....

By Patrick McConnell

Law & Politics

16 Jun 2022

Intellectual Property Due Diligence in Psychedelics

Psychedelic patent portfolios require an understanding of the unique characteristics of the industry....

By Jayashree Mitra

Join Our Newsletter for Exclusive Updates, Stories, and More

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result